 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Using the Conture® Multi-Lumen Balloon to Deliver Accelerated Partial Breast Brachytherapy
|
|
|
|
Phase IV
|
|
|
|
SENORX-S07-002
NCT00699101
|
|
| |
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
|
|
|
|
Phase III
|
|
|
|
NSABP-B-39
RTOG-0413, SWOG-NSABP-B-39, NSABP-B-39, NCT00103181
|
|
| |
Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients
|
|
|
|
Phase III
|
|
|
|
2006-0827
NCT00481884
|
|
| |
Lapatinib in Treating Women With Ductal Carcinoma In Situ of the Breast
|
|
|
|
Phase II, Phase I
|
|
|
|
BCM-H-19895
H-19895, BCM-P50-CA-58183, NCT00555152
|
|
| |
Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ
|
|
|
|
Phase II
|
|
|
|
UMN-2002LS097
UMN-0211M35761, NCT00290654
|
|
| |
Chemoprevention Trial - Anastrozole in DCIS in Postmenopausal Women
|
|
|
|
Phase II
|
|
|
|
UCI 03-16
NCT00256217
|
|
| |
Simvastatin and Anastrozole in Treating Postmenopausal Women With Invasive Breast Cancer, Ductal Carcinoma In Situ, or a High Risk of Breast Cancer
|
|
|
|
Phase II
|
|
|
|
JHOC-J05100
JHOC-SKCCC-J05100, NCT00354640
|
|
| |
Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer
|
|
|
|
Phase II
|
|
|
|
UCSF-047522
UCSF-H8409-26206-01, MSKCC-06041, NCT00416403
|
|
| |
Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast
|
|
|
|
Phase II
|
|
|
|
1B-06-9
NCT00556907
|
|
| |
Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia
|
|
|
|
Phase II
|
|
|
|
OHSU-3872
3872, OHSU-CTRC-1037, NCT00627276
|
|
